FDA Inspection
Raptim Research Pvt. Ltd.Raptim Research Pvt. Ltd. – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Raptim Research Pvt. Ltd., with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fb156f41-91ac-4088-85ff-7e4b5cbf4a22
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1092649
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Raptim Research Pvt. Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | Not classified | Office of Inspections and Investigations | |
| July 25, 2025 | Not classified | Office of Inspections and Investigations | |
| April 28, 2023 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 14, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 19, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Raptim Research Pvt. Ltd.
- FDA Inspection 1281156 - 2025-07-25
- FDA Inspection 1281109 - 2025-07-25
- FDA Inspection 1211275 - 2023-04-28
- FDA Inspection 1181097 - 2022-09-14
- FDA Inspection 1110477 - 2019-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.